Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Avecia Healthcare is an Indian pharmaceutical company focused on commercialized generic and branded-generic formulations rather than novel drug discovery. The company markets a broad portfolio of more than 500 formulations across tablets, capsules, softgels, syrups, injectables, ointments, ophthalmics, dermatology products, and related dosage forms, and also offers PCD pharma franchise and third-party manufacturing services. Its business appears centered on distribution, marketing, and outsourced manufacturing through WHO-GMP-certified facilities serving partners across India. Therapeutic coverage spans anti-infectives, cardiometabolic, gastroenterology, dermatology, gynecology, nephrology, neuropsychiatry, ophthalmology, anti-obesity, and other general medicine categories. The company is led by Vaibhav Aggarwal/Agarwal and operates from Delhi with additional listed sites in Haryana.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Avecia Healthcare.